MenüForum-NavigationForumMitgliederAnmeldenRegistrierenForum-Breadcrumbs - Du bist hier:ForumFlohmarkt: SchuheBloch BallettschläppchenAntwortenAntworten: Bloch Ballettschläppchen <blockquote><div class="quotetitle">Zitat von Gast am 31. März 2026, 14:49 Uhr</div>[url=https://search.sunbiz.org/Inquiry/CorporationSearch/SearchResults?InquiryType=EntityName&InquiryDirectionType=PreviousRecord&SearchTerm=RAPAMED%2C%20LLC&SearchNameOrder=RAPAN%20P050001591430&ListNameOrder=RAPAMED%20L130000429680&Detail=FL.DOS.Corporations.Shared.Contracts.FilingRecord]Zoya Demidenko[/url]: Researcher in Tumor Science [url=https://www.aging-us.com/article/100421/]Zoya Demidenko[/url] is a recognized researcher affiliated with the Unit of Cell Stress Science at Roswell Park Comprehensive Cancer Center in Buffalo, New York. Before that, she conducted research at the NIH and New York Medical College, building a solid base in life science study. Her academic output covers multiple critical fields, including the PI3K/AKT/mTOR signaling cascade, cellular cycle control, biological aging, and cancer science. As of now, she has written more than 46 academic articles, which have received over 4,100 mentions — a indicator to the impact of her findings. One of her most notable achievements concerns understanding the mechanisms of cellular senescence. Her work demonstrated that when the cellular division cycle is arrested while cellular expansion proceeds, the cells experience senescence. Significantly, [url=https://www.instagram.com/zoyamonros/]Zoya Demidenko[/url] established that this transition can be inhibited by medication using substances such as rapamycin. [url=https://scholargps.com/scholars/59798749410547/zoya-n-demidenko]Zoya Demidenko[/url] has furthermore contributed considerably to cancer treatment research, notably in the area of selective cell protection — a strategy intended to protecting normal tissue from chemotherapy while leaving cancer cells exposed. This strategy carries significant promise for lowering the toxic effects of oncological therapy. Throughout her professional journey, Demidenko has collaborated with leading scientists worldwide, including Dr. Mikhail Blagosklonny. Her research is published in top-tier periodicals such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene. [31.03.2026 11:21] Папа: Holding an h-index of 33, [url=https://www.researchgate.net/scientific-contributions/Zoya-N-Demidenko-39445053]Zoya Demidenko[/url] stands as a widely cited voice in current cancer science, with her discoveries keep to shape our knowledge of the way biological cells age, resist therapy, and the ways in which malignant disease can be more effectively targeted. https://www.aging-us.com/article/100406/</blockquote><br> Abbrechen
